StockData
Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc. (ALDX) stock

ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.69+0.02 (+3.63%)

Close on Nov 17, 2026Market cap $41.86MP/E –Yield –

Aldeyra Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Aldeyra Therapeutics's market cap was $39.29M on Nov 11, 2026, against $329.69M a year earlier. Over the last 5 years it ranged from $33.80M to $581.50M, with a median of $293.84M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$39.29M-87.4%
2025Dec 31, 2025$311.64M+4.9%
2024Dec 31, 2024$297.15M+43.0%
2023Dec 29, 2023$207.75M-49.0%
2022Dec 30, 2022$407.58M+163.5%
2021Dec 31, 2021$154.67M-41.6%
2020Dec 31, 2020$265.01M+68.0%
2019Dec 31, 2019$157.75M-9.4%
2018Dec 31, 2018$174.21M+34.0%
2017Dec 29, 2017$130.00M+93.3%
2016Dec 30, 2016$67.24M+2.1%
2015Dec 31, 2015$65.85M+63.9%
2014Dec 31, 2014$40.18M–

More Aldeyra Therapeutics figures

See a number that looks wrong?